(lp0
S"Here's Why Ligand Pharmaceuticals Inc Is Plunging Today Motley Fool - Sep 27, 2016 Shares of Ligand Pharmaceuticals , an owner of royalty assets in the healthcare space, are falling by more than 13% as of 3:30 p.m.Amgen's Multiple Myeloma Drug Bumbles Key Test Vs. Blockbuster Velcade - Investor's Business Daily"
p1
aS'Ligand Pharmaceuticals Inc Reports 31% Increase In Q4 Bottom Line Nasdaq - Feb 23, 2017  - Ligand Pharmaceuticals Inc  reported earnings for its fourth quarter that climbed compared to the same period last year.'
p2
aS'Licensing Agreements Drive Ligand Pharmaceuticals Inc. 13% Higher in July Motley Fool - Aug 8, 2016 What: Shares of Ligand Pharmaceuticals , an acquirer of royalty assets in the biotech space, surged 13% in July, according to data from S&amp;P Global Market Intelligence.'
p3
aS'Ligand Pharmaceuticals Incorporated  Moves Higher on Volume Spike for ... Equities.com - 17 hours ago Ligand Pharmaceuticals Incorporated has a P/B ratio of 6.71. Ligand Pharmaceuticals Inc is a biopharmaceutical company with a business model that is based upon the concept of developing or acquiring royalty revenue generating assets and coupling them&nbsp;...'
p4
aS'Lawsuit for Investors in Ligand Pharmaceuticals Inc.  over ... GlobeNewswire  - Nov 29, 2016 SAN DIEGO, Nov. 29, 2016  -- The Shareholders Foundation, Inc. announces that a lawsuit was filed in California on behalf of certain purchasers of shares of Ligand Pharmaceuticals Inc.  over alleged Securities Laws&nbsp;...'
p5
aS"Analyst Update: Alphabet Inc, Facebook Inc, and Ligand Pharmaceuticals Inc. Schaeffers Research  - Sep 27, 2016 Analysts are weighing in on internet issue Alphabet Inc , social media stock Facebook Inc , and drugmaker Ligand Pharmaceuticals Inc. . Here's a quick roundup of today's brokerage notes on GOOGL, FB,&nbsp;..."
p6
aS'Ligand Pharmaceuticals Inc. Investigated For Securities Fraud By Block ... PR Newswire  - Nov 16, 2016 BOSTON, Nov. 15, 2016 /PRNewswire/ -- Block &amp; Leviton LLP , a securities litigation firm representing investors nationwide, is investigating whether Ligand Pharmaceuticals Inc.  and certain of its officers and directors&nbsp;...'
p7
aS'The Ligand Pharmaceuticals Inc.  Given Consensus Recommendation of Buy ... Petro Global News 24 - Mar 17, 2017 Shares of Ligand Pharmaceuticals Inc.  have received a consensus rating of Buy from the nine ratings firms that are presently covering the stock.'
p8
aS'Ligand Pharmaceuticals Inc.  Given Consensus Recommendation of Buy by ... The Cerbat Gem - Mar 16, 2017 Ligand Pharmaceuticals logo Ligand Pharmaceuticals Inc.  has been assigned an average rating of Buy from the nine analysts that are covering the company.'
p9
aS'Ligand Pharmaceuticals Inc.: Ligand Reports Fourth Quarter and Full Year 2016 ... The Wall Street Transcript - Feb 23, 2017 SAN DIEGO---- Ligand Pharmaceuticals Incorporated  today reported financial results for the three and 12 months ended December 31, 2016, and provided an operating forecast and program updates.'
p10
a.